Jane Street Group LLC Acquires 10,759 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Jane Street Group LLC raised its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 124.0% in the third quarter, Holdings Channel reports. The fund owned 19,436 shares of the company’s stock after purchasing an additional 10,759 shares during the quarter. Jane Street Group LLC’s holdings in VanEck Pharmaceutical ETF were worth $1,847,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in PPH. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of VanEck Pharmaceutical ETF by 51.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock worth $23,565,000 after buying an additional 84,273 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in VanEck Pharmaceutical ETF by 33.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock worth $22,322,000 after purchasing an additional 59,025 shares in the last quarter. Miller Investment Management LP raised its position in VanEck Pharmaceutical ETF by 13.4% in the third quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock valued at $19,722,000 after purchasing an additional 24,446 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of VanEck Pharmaceutical ETF by 1.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 160,039 shares of the company’s stock valued at $14,641,000 after purchasing an additional 2,694 shares in the last quarter. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management bought a new stake in shares of VanEck Pharmaceutical ETF during the third quarter worth about $8,743,000.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ PPH opened at $87.70 on Thursday. The company has a 50 day simple moving average of $89.82 and a 200 day simple moving average of $92.79. VanEck Pharmaceutical ETF has a 1 year low of $80.57 and a 1 year high of $99.51. The firm has a market cap of $648.10 million, a PE ratio of 21.04 and a beta of 0.72.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.